You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 168 No. 3, February 11, 2008 TABLE OF CONTENTS
  Archives
  •  Online Features
  Editor's Correspondence
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related letter
 •Related articles
 •Similar articles in this journal
 Topic Collections
 •Drug Therapy, Other
 •Thyroid/ Parathyroid Diseases
 •Otolaryngology/ Head & Neck Surgery
 •Endocrine Disease of Head & Neck
 •Alert me on articles by topic

COMMENTS & OPINIONS
Whether to Repeat Thyroid Disease Screening

Bernard Goichot, MD, PhD; Stéphane Vinzio, MD

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

We read with great interest the article by Meyerovitch et al1 on the follow-up of thyrotropin (TSH) measurements in the community. Although we share the authors' opinion on patient treatment and we acknowledge the convincing demonstration of the amazing costs of the current clinical bad practices, we think that the study has a major bias that prevents one to draw definitive conclusions. The authors stated that "to study the natural history," 37% of patients who received treatment with levothyroxine or antithryoid drugs after the initial TSH determination were excluded.1(p1534) It is not mentioned how many of these patients had either increased or decreased TSH levels.

One cannot exclude that these patients have been identified by their primary care physicians as being at risk of evolution toward an overt form of hyperthyroidism or hypothyroidism. As underlined by the authors, these risk factors are well . . . [Full Text of this Article]


AUTHOR INFORMATION

RELATED LETTER

Whether to Repeat Thyroid Disease Screening—Reply
Joseph Meyerovitch, Pnina Rotman-Pikielny, Michael Sherf, Erez Battat, Yair Levy, and Martin I. Surks
Arch Intern Med. 2008;168(3):330-331.
EXTRACT | FULL TEXT  

RELATED ARTICLES

Serum Thyrotropin Measurements in the Community: Five-Year Follow-up in a Large Network of Primary Care Physicians
Joseph Meyerovitch, Pnina Rotman-Pikielny, Michael Sherf, Erez Battat, Yair Levy, and Martin I. Surks
Arch Intern Med. 2007;167(14):1533-1538.
ABSTRACT | FULL TEXT  

Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management
Martin I. Surks, Eduardo Ortiz, Gilbert H. Daniels, Clark T. Sawin, Nananda F. Col, Rhoda H. Cobin, Jayne A. Franklyn, Jerome M. Hershman, Kenneth D. Burman, Margo A. Denke, Colum Gorman, Richard S. Cooper, and Neil J. Weissman
JAMA. 2004;291(2):228-238.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2008 American Medical Association. All Rights Reserved.